Раскройте тайны своей усталости: 12 шагов для подзарядки энергией, исцеления тела и трансформации

92. Dunlavey, C.J. (2018), ‘Introduction to the HypothalamicPituitary-Adrenal Axis: Healthy and Dysregulated Stress Responses, Developmental Stress and Neurodegeneration’: www.ncbi.nlm.nih.gov/pubmed/30057514.

Глава 9. Пищеварительная система и источники энергии

93. Sender, R., et al. (2016), ‘Revised Estimates for the Number of Human and Bacteria Cells in the Body’: www.ncbi.nlm.nih.gov/pmc/articles/PMC4991899/.

94. Belkaid, Y. and Hand, T.W. (2014), ‘Role of the microbiota in immunity and inflammation’: www.ncbi.nlm.nih.gov/pubmed/24679531.

95. Carabotti, M., et al. (2015), ‘The gut — brain axis: interactions between enteric microbiota, central and enteric nervous systems’: www.ncbi.nlm.nih.gov/pubmed/ 25830558.

96. Ma, Q., et al. (2019), ‘Impact of microbiota on central nervous system and neurological diseases: the gut — brain axis’: https://jneuroinflammation.biomed.central.com/articles/10.1186/s12974-019-1434-3.

97. Bischoff, S.C., et al. (2014), ‘Intestinal permeability — a new target for disease prevention and therapy’: www.ncbi.nlm.nih.gov/pmc/articles/PMC4253991/.

98. Li, Y, et al. (2018), ‘The Role of Microbiome in Insomnia, Circadian Disturbance and Depression’, Frontiers in Psychiatry, 9(December):1–11.

99. Appleton, J. (2018), ‘The Gut — Brain Axis: Influence of Microbiota on Mood and Mental Health’: www.ncbi.nlm.nih.gov/pmc/articles/PMC6469458/.

100. D’Mello, C., et al. (2015), ‘Probiotics Improve Inflammation-Associated Sickness Behavior by Altering Communication between the Peripheral Immune System and the Brain’: www.jneurosci.org/content/35/30/10821.full.

101. Ganci, M., et al.

(2019), ‘The role of the brain — gut — microbiota axis in psychology: The importance of considering gut microbiota in the development, perpetuation, and treatment of psychological disorders’: www.ncbi.nlm.nih.gov/pmc/articles/PMC6851798/.

102. Parkar, S.G., et al. (2019), ‘Potential role for the gut microbiota in modulating host circadian rhythms and metabolic health’, Microorganisms, 7(2):1–21.

103. Fasano, A. (2020), ‘All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases’: www.ncbi.nlm.nih.gov/pubmed/32051759F1000.

104. Kolacz, J. and Porges, S.W. (2018), ‘Chronic Diffuse Pain and Functional Gastrointestinal Disorders After Traumatic Stress: Pathophysiology Through a Polyvagal Perspective’: www.ncbi.nlm.nih.gov/pubmed/29904631.

105. Maes, M. and Twisk, F.N. (2009), ‘Why myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) may kill you: disorders in the inflammatory and oxidative and nitrosative stress (IO&NS) pathways may explain cardiovascular disorders in ME/CFS’: www.ncbi.nlm.nih.gov/pubmed/20038921.

106. Maes, M. (2009), ‘Inflammatory and oxidative and nitrosative stress pathways underpinning chronic fatigue, somatization and psychosomatic symptoms’: www.ncbi.nlm.nih.gov/pubmed/19127706.

107. Yu, LC-H. (2018), ‘Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis’: www.ncbi.nlm.nih.gov/pmc/articles/PMC6234774/.

108. Bures, J., et al. (2006), ‘Small intestinal bacterial overgrowth syndrome’, World Journal of Gastroenterology, 16(24):2978–90.

109. Saffouri, G.B., etal. (2019), ‘Small intestinal microbial dysbiosis underlies symptoms associated with functional gastrointestinal disorders’: www.ncbi.nlm.nih.gov/ pmc/articles/PMC6494866/.

110. Sachdev, A.H. and Pimentel, M. (2013), ‘Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance’: www.ncbi.nlm.nih.gov/pubmed/ 23997926.

111. Pimentel, M., et al. (2004), ‘A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing’: www.ncbi.nlm.nih.gov/pubmed/15020342.

Глава 10. Гормоны и резервная энергетическая система тела

112. Cadegiani, F.A. and Kater, C.E. (2016), ‘Adrenal fatigue does not exist: a systematic review’: www.ncbi.nlm.nih.gov/pmc/articles/PMC4997656/.

113. Wyller, V.B., et al. (2016), ‘Altered neuroendocrine control and association to clinical symptoms in adolescent chronic fatigue syndrome: a crosssectional study’: www.ncbi.nlm.nih.gov/pubmed/27149955.

114. Torres-Harding, S., et al. (2008), ‘The associations between basal salivary cortisol and illness symptomatology in chronic fatigue syndrome’: www.ncbi.nlm.nih.gov/pmc/articles/PMC2730359/.

115. Ludwig, D.S. (2014), ‘Clinical update: the low-glycaemic-index diet. https://www.thelancet.com/journals/lancet/article/PIIS01406736%2807%2960427-9/fulltext.

116. Savage, D.B., et al. (2007), ‘Disordered Lipid Metabolism and the Pathogenesis of Insulin Resistance’: www.ncbi.nlm.nih.gov/pmc/articles/PMC2995548/.